SMMT Heads Into Earnings With Insiders Buying and Shorts Watching
Summit Therapeutics enters its Q2 earnings release — scheduled for July 23 after hours — with a striking insider conviction signal, a rebuilding short position, and an analyst community that remains deeply divided. The…